Enhancing the QUAlity and Transparency Of health Research

Website translation help
Navigate this website
Home > Library > Reporting guideline > ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis

Search for reporting guidelines

Use your browser's Back button to return to your search results

ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)		 Reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
Full bibliographic reference Dougados M, Simon P, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, van der Heijde D. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis. 2011;70(2):249-251.
Language English
PubMed ID 20829199
Study design Clinical trials, Experimental studies
Clinical area Rheumatology
Applies to the whole report or to individual sections of the report? Data
Record last updated on January 27, 2015

Reporting guidelines for main study types

Translations

Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.

Library index